Hap Trading, LLC Adma Biologics, Inc. Call Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	SELL	$3.01 - $3.87 $93,611 - $120,357	-31,100 Reduced 53.44%	27,100 $1,000
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $43,719 - $68,676	17,700 Added 43.7%	58,200 $42,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $19,690 - $27,742	9,700 Added 31.49%	40,500 $13,000
Q2 2022 Aug 12, 2022	SELL	$1.43 - $2.2 $7,007 - $10,780	-4,900 Reduced 13.73%	30,800 $5,000
Q1 2022 May 12, 2022	SELL	$1.28 - $1.83 $25,600 - $36,600	-20,000 Reduced 35.91%	35,700 $9,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $23,108 - $35,192	21,200 Added 61.45%	55,700 $2,000
Q3 2021 Nov 10, 2021	BUY	$1.13 - $1.65 $4,407 - $6,435	3,900 Added 12.75%	34,500 $5,000
Q2 2021 Aug 11, 2021	SELL	$1.51 - $2.07 $32,918 - $45,126	-21,800 Reduced 41.6%	30,600 $4,000
Q1 2021 May 14, 2021	SELL	$1.67 - $2.95 $88,009 - $155,465	-52,700 Reduced 50.14%	52,400 $9,000
Q4 2020 Feb 16, 2021	BUY	$1.8 - $2.56 $26,460 - $37,632	14,700 Added 16.26%	105,100 $13,000
Q3 2020 Nov 13, 2020	BUY	$2.04 - $3.74 $116,280 - $213,180	57,000 Added 170.66%	90,400 $30,000
Q2 2020 Aug 10, 2020	BUY	$2.42 - $3.29 $80,828 - $109,886	33,400 New	33,400 $4,000

319

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $4.16B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.